The Valley Desk

ArticleOpen forum infectious diseasesPublished

Implementation of Injectable Cabotegravir/Rilpivirine for Treatment of Human Immunodeficiency Virus in Patients With Substance Use Disorders at a Syringe Exchange Clinic

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Open forum infectious diseases
Published
Subject terms
Human immunodeficiency virus; Rilpivirine; Syringe Exchange; Opioid Use Disorder; Cabotegravir
PubMed ID
39553286
PubMed Central ID
PMC11565405
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal